UNIVPHOTO.BO Universus Photo Imagings (BSE) +26.74% 16 Feb 2026: model +22.98%

UNIVPHOTO.BO stock led BSE after-hours gains on 16 Feb 2026 after a +26.74% move to INR 266.15. The jump followed thin-volume trading (volume 3,995.00 vs avg 750.00) and came after an earnings update earlier in February. Traders pushed the price above the 50-day average of INR 219.44, triggering short-term momentum flows.

Price action snapshot for UNIVPHOTO.BO stock

Universus Photo Imagings Limited (UNIVPHOTO.BO) closed the session at INR 266.15, up 26.74% from the previous close of INR 210.00. The day range was INR 255.35–278.90, year high INR 333.80 and year low INR 174.20. Trading volume was 3,995.00 shares against an average of 750.00, reflecting high relative volume and volatility.

Catalysts and news driving the move

The price surge followed the company’s earnings announcement dated 10 Feb 2026 and visible repositioning by traders in the small-cap healthcare names. Universus reported results that kept EPS negative at -139.74, which can spur speculative trading in low-float names. With only 10,946,604.00 shares outstanding, even modest buy orders can push the stock significantly higher on the BSE.

Fundamentals and valuation snapshot

UNIVPHOTO.BO shows mixed fundamentals: a negative PE of -1.83 with EPS -139.74, but a low price-to-book of 0.33 and cash per share of INR 242.65. Book value per share stands at INR 768.33, and market capitalization is INR 2,758,544,208.00. These metrics show asset backing but weak profitability, creating a valuation split investors must weigh.

Technicals and trading levels to watch

Momentum indicators point to short-term stress: RSI at 31.57 (near oversold), MACD histogram slightly negative, and CCI deeply oversold. Key technical levels: immediate support near INR 255.35, near-term resistance at INR 278.90, 50-day average INR 219.44, and 200-day average INR 246.26. Low average volume historically suggests wide intraday swings; set tight risk controls when trading this BSE listing.

Meyka AI rates and model forecast for UNIVPHOTO.BO

Meyka AI rates UNIVPHOTO.BO with a score out of 100: 70.33 / B+ — BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of INR 327.28, implying an upside of 22.98% versus the current price INR 266.15. Forecasts are model-based projections and not guarantees.

Sector context and risk factors

UNIVPHOTO.BO trades in the Healthcare sector (Medical – Devices) where the broader sector YTD performance is weak at around -2.29%. Primary risks here are continued negative earnings, inventory slowdown (days of inventory 145.47), and low liquidity. Opportunities include large tangible book value (INR 768.33 per share) and cash cushion (INR 242.65 per share) if management executes a turnaround.

Final Thoughts

UNIVPHOTO.BO stock’s +26.74% after-hours move on 16 Feb 2026 highlights the stock’s sensitivity to news and low free float on the BSE in India. Fundamentals show a firm asset base — book value INR 768.33 and cash per share INR 242.65 — but profitability remains negative with EPS -139.74 and PE -1.83. Technically, buyers pushed price above the 50-day average INR 219.44, but RSI 31.57 and thin volumes keep the setup risky for momentum traders. Meyka AI’s forecast model projects a yearly target of INR 327.28, an implied upside of 22.98% from INR 266.15, while a nearer-term monthly model sits at INR 240.55. Investors should balance the upside vs valuation and liquidity risks, watch support at INR 255.35, and use position sizing to manage volatility. For continuous coverage and real-time signals, see the company site source and the BSE quote source. Meyka AI provided this AI-powered market analysis; forecasts are model outputs, not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.